The European market for heart valve devices will grow through 2027, fueled by an expanding aging population and rising adoption THV devices, reflecting the accumulation of favorable clinical data for the use of these devices for patient populations usually treated with surgical devices.

This Medtech 360 Report provides high-level market metrics for heart valve devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents

  • Heart Valve Devices - Market Insights - Europe (Supplemental)

Author(s): Drew Wallace

Drew C. Wallace is an analyst on the Cardiovascular Medtech Insights team, specializing in heart valve and cardiac rhythm management device markets. Drew holds a Master's degree in Developmental Biology from the University of Western Ontario. Prior to his current position, Drew worked at the Princess Margaret Cancer Centre on the immunotherapy clinical trial program. 


Related Reports

Heart Valve Devices - Market Insights - Europe

The European heart valve devices market will grow through 2029, fueled by the rapid adoption of THV devices and an aging population. Clinical investig...

View Details

Heart Valve Devices - Market Insights - Japan

The Japanese heart valve device market is large and expanding, with growth being driven primarily by the rapid...

View Details

Heart Valve Devices - Market Insights - United States

The US heart valve device market is the largest in the world and it continues to grow rapidly, due largely to the swift adoption of THV de...

View Details

Heart Valve Devices - Market Insights - Latin America (Supplemental)

The Latin American heart valve device market will experience robust growth, largely driven by an expanding patient pool, improving access t...

View Details